2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer

By S. Baum. 2002

1,542 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America (2009, background): “Refer to the 2002 IDSA guidelines for the use of antimicrobial agents in neutropenic patients with cancer [111].”
Chemotherapy‐induced neutropenia (2004, background): “The most common organisms that infect patients with cancer and neutropenia in general, as well as the most common causes of bacteremia, are gram-negative rods, such as Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa, and aerobic, gram-positive cocci, such as Staphylococcus and St”
Guidelines for treatment of candidiasis. (2004, background): “This clinical condition has recently been reviewed, and there is a related guideline from the IDSA [134].”
Practice guidelines for the diagnosis and management of skin and soft-tissue infections. (2005, background): “aeruginosa, but there is wide variability in the pathogens isolated in different treatment centers [159, 160, 164, 165].”
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. (2008, methodology): “Throughout this document, treatment recommendations are rated according to the standard scoring system of the Infectious Diseases Society of America and United Stated Public Health Service for rating recommendations in clinical guidelines, as summarized in table 1.”